Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $2.38 billion. The enterprise value is $2.32 billion.

Market Cap	2.38B
Enterprise Value	2.32B

Important Dates

The next estimated earnings date is Thursday, July 30, 2026, after market close.

Earnings Date	Jul 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Biohaven has 150.56 million shares outstanding. The number of shares has increased by 23.59% in one year.

Current Share Class	150.56M
Shares Outstanding	150.56M
Shares Change (YoY)	+23.59%
Shares Change (QoQ)	+22.82%
Owned by Insiders (%)	10.81%
Owned by Institutions (%)	89.58%
Float	124.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	18.40
P/TBV Ratio	21.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.41, with a Debt / Equity ratio of 2.21.

Current Ratio	7.41
Quick Ratio	6.68
Debt / Equity	2.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -333.00% and return on invested capital (ROIC) is -108.56%.

Return on Equity (ROE)	-333.00%
Return on Assets (ROA)	-83.38%
Return on Invested Capital (ROIC)	-108.56%
Return on Capital Employed (ROCE)	-148.97%
Weighted Average Cost of Capital (WACC)	20.02%
Revenue Per Employee	n/a
Profits Per Employee	-$2.36M
Employee Count	274
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biohaven has paid $1.11 million in taxes.

Income Tax	1.11M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.47% in the last 52 weeks. The beta is 3.30, so Biohaven's price volatility has been higher than the market average.

Beta (5Y)	3.30
52-Week Price Change	+10.47%
50-Day Moving Average	10.82
200-Day Moving Average	11.56
Relative Strength Index (RSI)	74.63
Average Volume (20 Days)	3,947,187

Short Selling Information

The latest short interest is 25.25 million, so 16.77% of the outstanding shares have been sold short.

Short Interest	25.25M
Short Previous Month	24.87M
Short % of Shares Out	16.77%
Short % of Float	20.36%
Short Ratio (days to cover)	10.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-617.23M
Pretax Income	-646.57M
Net Income	-647.68M
EBITDA	-607.19M
EBIT	-617.23M
Earnings Per Share (EPS)	-$5.44

Full Income Statement

Balance Sheet

The company has $347.82 million in cash and $286.18 million in debt, giving a net cash position of $61.64 million or $0.41 per share.

Cash & Cash Equivalents	347.82M
Total Debt	286.18M
Net Cash	61.64M
Net Cash Per Share	$0.41
Equity (Book Value)	129.50M
Book Value Per Share	0.86
Working Capital	333.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$594.23 million and capital expenditures -$254,000, giving a free cash flow of -$594.49 million.

Operating Cash Flow	-594.23M
Capital Expenditures	-254,000
Depreciation & Amortization	10.04M
Net Borrowing	250.00M
Free Cash Flow	-594.49M
FCF Per Share	-$3.95

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.59%
Shareholder Yield	-23.59%
Earnings Yield	-27.17%
FCF Yield	-24.94%

Analyst Forecast

The average price target for Biohaven is $21.71, which is 37.15% higher than the current price. The consensus rating is "Buy".

Price Target	$21.71
Price Target Difference	37.15%
Analyst Consensus	Buy
Analyst Count	19
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2